CTOs on the Move

Therapy Management Corporation

www.therapymgmt.com

 
Therapy Management Corporation is a Homosassa, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Comprehensive NeuroScience

Comprehensive NeuroScience, Inc. is a Hollywood, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

The Quigley Corporation

The Quigley Corporation is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Doylestown, PA. To find more information about The Quigley Corporation, please visit www.quigleyco.com

Jefferson Health System

Headquartered in Radnor, Pennsylvania, Jefferson Health System is the largest health system in Southeastern Pennsylvania. Jefferson Health System does not provide any care directly and does not control the delivery of patient care. All patient care is provided by the system`s members.

Palm Medical Centers

Founded in 2013, Palm Medical Centers is a provider of value-based, capitated primary care services with a focus on high-quality clinical outcomes, cost-effective care, and a patient-centric experience. Operating a network of 19 medical centers across five counties in Florida, PMC serves more than 34,000 Medicare Advantage and managed Medicaid patients. Partnering with numerous managed care organizations, Palm Medical Centers offers comprehensive and integrated medical care to plan members with a focus on quality. In addition to primary care services, the company coordinates cardiology, dentistry, optometry, pediatrics, podiatry, psychiatry and other specialist services. Palm Medical Centers continues to seek partnership opportunities with high quality providers in existing and new markets.

Knight Therapeutics Inc

Knight Therapeutics Inc., headquartered in Montreal, Canada, is a specialty pharmaceutical company focused on acquiring or in-licensing innovative pharmaceutical products for the Canadian and world markets. Knight Therapeutics' shares are expected to begin trading on the TSX-V on March 3, 2014 under the symbol GUD.